NARZAHNI CRUMBIE: Open Payments
NPI 1821554999 · ORO VALLEY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,329 in 149 payments from 16 companies in 2025. Trend: 2023 $859 · 2024 $15,114 · 2025 $6,329
Speaker / faculty: $3,500Food & beverage: $2,636Travel & lodging: $126Education: $67
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 15 | $3,725 |
| Janssen Biotech, Inc. | 24 | $440 |
| ABBVIE INC. | 20 | $392 |
| Madrigal Pharmaceuticals | 4 | $368 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 21 | $225 |
| Ardelyx, Inc. | 7 | $203 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $176 |
| PFIZER INC. | 12 | $160 |
| Regeneron Healthcare Solutions, Inc. | 5 | $153 |
| Novo Nordisk Inc | 2 | $136 |
Products named: VOQUEZNA, TREMFYA, REZDIFFRA, IBSRELA, XIFAXAN, ENTYVIO, Wegovy, ZENPEP.
Industry payments across AZ — which companies pay providers there.
